Readoutin 14d
Suzhou Suncadia Biopharmaceuticals Co., Ltd. — SHR-A2009 monotherapy
Phase 3 primary completion: A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC.
- Date
- Dec 2026
- Type
- Readout
- Indication
- Non-small Cell Lung Cancer